Application 077263
- Type
- ANDA
- Sponsor
- TEVA PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | RIZATRIPTAN BENZOATE | RIZATRIPTAN BENZOATE | TABLET;ORAL | EQ 5MG BASE | No | No |
| 002 | RIZATRIPTAN BENZOATE | RIZATRIPTAN BENZOATE | TABLET;ORAL | EQ 10MG BASE | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0093-7471 | Rizatriptan Benzoate | Rizatriptan Benzoate | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-7471 | Rizatriptan Benzoate | Rizatriptan Benzoate | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-7472 | Rizatriptan Benzoate | Rizatriptan Benzoate | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-7472 | Rizatriptan Benzoate | Rizatriptan Benzoate | Teva Pharmaceuticals USA, Inc. | ANDA | Current |